Updated
Updated · Ars Technica · Oct 14
Researchers Use AI to Build 2 Protease Types That Cut Neurological-Disease Proteins
Updated
Updated · Ars Technica · Oct 14

Researchers Use AI to Build 2 Protease Types That Cut Neurological-Disease Proteins

3 articles · Updated · Ars Technica · Oct 14

Summary

  • AI-based protein design tools let researchers create new enzymes that cut selected proteins in half, and they demonstrated the approach on proteins tied to neurological diseases.
  • 2 protease mechanisms underpinned the work: the team kept each catalytic core but replaced the rest of the protein, effectively bypassing the long natural diversification of proteases.
  • peptide bonds are otherwise extremely stable—with half-lives of several hundred years in water—so the result points to a way to engineer highly targeted protein-cutting enzymes rather than rely on naturally evolved ones.
  • The study suggests custom proteases could become a platform for attacking disease-linked proteins, extending enzyme design beyond existing natural protein-digesting systems.

Insights

Could AI-designed enzymes that precisely slice apart disease-causing proteins finally cure untreatable neurological disorders like Alzheimer's?
Beyond human disease, could these custom AI enzymes be reprogrammed to digest environmental microplastics or synthetic waste?
What happens if these hyper-efficient, lab-created AI proteases mutate and begin destroying healthy human proteins?